Microsoft Internet Explorer 6 and below will not provide the best experience while visiting this website.Please consider upgrading your browser to one of the modern browsers below:
AMITIZA (lubiprostone) is indicated for the treatment of Chronic Idiopathic Constipation (24 mcg twice daily) in adults and for Irritable Bowel Syndrome with Constipation (8 mcg twice daily) in women ≥ 18 years old.
This site is intended for use by U.S. residents only. This site is intended for healthcare professionals.
AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license byTakeda Pharmaceuticals America, Inc.
©2013 Takeda Pharmaceuticals U.S.A., Inc.